Editorial · 2013
PerspectivePublished 28 Mar 2022
Anti-TB Medication Development
Keywords
Subjects
Genetics & Molecular BiologySimilar by topic
Conference abstract · 2019
Isoniazid-oleanolic acid co-crystal system: Synthesis, anti-TB and toxicological effect on the human embryonic kidney (HEK293) and human hepatocellular carcinoma (HepG2) cell lines
Short communication · 29 Aug 2024
Adverse Effects and Drug Interactions of Anti-TB Medications: Management and Prevention
Conference abstract · 2021
Mycobacterium tuberculosis hiding in mesenchymal stem cells are unresponsive to anti-TB drugs- a possible role of ABCG2 efflux pumps
Conference abstract · 16 Sep 2022
Isoniazid-oleanolic acid co-crystal system: Synthesis, anti-TB and toxicological effect on the Human Embryonic Kidney (HEK293) and Human Hepatocellular Carcinoma (HepG2) cell lines
More from this journal
The newest in Molecular Biology: Open Access.
Brief report · 29 Dec 2025
Molecular Foundations of Cellular Life: Mechanisms and Dynamics
Commentary · 29 Dec 2025
Molecular Insights: Advancing Biology and Therapeutics
Brief report · 29 Dec 2025
Advancing Molecular Visualization and Understanding
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMolecular Biology: Open Access
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Heidari Heinz”

